← back to search

Antonio Hurtado‐Coll

University of British Columbia · CA
🔎 Find collaborators in Pulmonary and Respiratory Medicine · Endocrinology, Diabetes and Metabolism →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pulmonary and Respiratory Medicine · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Hormonal and reproductive studies, and Cancer, Lipids, and Metabolism.
h-index
32
citations
3,796
works
90
NIH funding
primary concept
email

Recent publications

Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for “large” cribriform prostatic adenocarcinoma
Modern Pathology 2022cited by 34position: middledoi
Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized
The American Journal of Surgical Pathology 2016cited by 133position: middledoi
Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH
Modern Pathology 2016cited by 90position: middledoi
Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies
Prostate Cancer and Prostatic Diseases 2016cited by 67position: middledoi
PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer
European Urology Focus 2015cited by 74position: middledoi
A multicenter study shows <i>PTEN</i> deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
The Prostate 2015cited by 67position: middledoi
DHH is an Independent Prognosticator of Oncologic Outcome of Clear Cell Renal Cell Carcinoma
The Journal of Urology 2014cited by 24position: middledoi
High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
Cancer Research 2013cited by 362position: middledoi
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer
The Journal of Pathology 2012cited by 195position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ladan Fazli · University of British Columbia8 papers (2013–2022)Martin Gleave · Prostate Cancer Canada7 papers (2013–2022)Dean A. Troyer · The University of Texas Health Science Center at Houston6 papers (2015–2022)Ian M. Thompson · Campbell Center for Historic Preservation Studies6 papers (2015–2022)James D. Brooks · Intel (United States)6 papers (2015–2022)Lawrence D. True · University of Washington Medical Center6 papers (2015–2022)Sarah T. Hawley · VA Ann Arbor Healthcare System6 papers (2015–2022)Jesse K. McKenney · Cleveland Clinic6 papers (2015–2022)Peter R. Carroll · UCSF Helen Diller Family Comprehensive Cancer Center6 papers (2015–2022)Ziding Feng · Seattle University6 papers (2015–2022)Peter S. Nelson · Bloodworks Northwest6 papers (2015–2022)Daniel W. Lin · University of Colorado Denver5 papers (2015–2022)Wei Wei · Yale Cancer Center4 papers (2015–2016)Lisa F. Newcomb · University of Michigan–Ann Arbor3 papers (2016–2022) · 3 papers (2015–2016)Maria Tretiakova · University of Washington3 papers (2016–2022)Hilary Boyer · Seattle University3 papers (2016–2022)Heidi Auman · Palo Alto University3 papers (2016–2022)Funda Vakar‐Lopez · University of Washington3 papers (2016–2022)Jeffrey P. Simko · University of California, San Francisco2 papers (2015–2016)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pulmonary and Respiratory Medicine · Endocrinology, Diabetes and Metabolism →